paroxetine has been researched along with Infantile Respiratory Distress Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ellfolk, M; Malm, H | 1 |
| Costei, AM; Ho, T; Ito, S; Koren, G; Kozer, E | 1 |
| Pham, B; Pryse-Phillips, W; Yuen, DE | 1 |
1 review(s) available for paroxetine and Infantile Respiratory Distress Syndrome
| Article | Year |
|---|---|
Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs).
Topics: Adult; Breast Feeding; Cardiovascular Abnormalities; Congenital Abnormalities; Female; Fluoxetine; Humans; Hypertension, Pulmonary; Infant, Newborn; Lactation; Maternal Exposure; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; PubMed; Respiratory Distress Syndrome, Newborn; Risk Assessment; Selective Serotonin Reuptake Inhibitors | 2010 |
2 other study(ies) available for paroxetine and Infantile Respiratory Distress Syndrome
| Article | Year |
|---|---|
Perinatal outcome following third trimester exposure to paroxetine.
Topics: Adult; Case-Control Studies; Female; Humans; Hypoglycemia; Infant, Newborn; Jaundice; Maternal-Fetal Exchange; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Pregnancy Trimester, Third; Prospective Studies; Respiratory Distress Syndrome, Newborn; Selective Serotonin Reuptake Inhibitors | 2002 |
Perinatal outcome following third-trimester exposure to paroxetine: an alternative interpretation.
Topics: Female; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, Third; Prospective Studies; Respiratory Distress Syndrome, Newborn; Selective Serotonin Reuptake Inhibitors | 2003 |